For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

Imperial College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias.

Type
D - Journal article
Title of journal
New England Journal of Medicine
Article number
-
Volume number
369
Issue number
19
First page of article
1783
ISSN of journal
0028-4793
Year of publication
2013
URL
-
Number of additional authors
29
Additional information

The author made a substantial contribution: to the conception and design of the study; to the organisation of the conduct of the study

The author helped: draft the output; critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
B - Cancer
Citation count
1
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-